In the one exception, a TGF-β signature reflecting basal gene expression differences between wild-type and TGFBR2 knockout mouse mammary tumor cells weakly correlated with good outcome in ER+ breast cancers [11]. The gene discussed is TGFBR2; the disease is breast cancer.